Home / Newswire


Weedstocks Newswire Feed

Weedstocks news RSS feed

MOOD™ Announces a Multi-Year Cannabis Accessories Supply Agreement with the Ontario Cannabis Store

2019-02-15 09:00:00

TORONTO, Feb. 15, 2019  /CNW/ - We are excited to share the news that MOODTM has been selected by the Ontario Cannabis Retail Corporation ("OCRC"), doing business as the Ontario Cannabis Store ("OCS") to supply the OCS with our premium MOOD branded cannabis accessories products.

"This initial supply agreement by MOODTM with a provincial government distributor is a tremendous step for our company and allows our premium MOOD cannabis accessories products to be showcased on the OCS website and available for purchase to private retailers throughout Ontario starting April 1st, " said Ken Tran, Founder and CEO of MOODTM.

"With this supply agreement in place MOOD will commence shipments to the OCS shortly and looks forward to having our products in front of consumers in Ontario for purchase in the upcoming weeks."

MOODTM has been and continues to actively pursue additional supply agreements with other provincial distributors as well as private retailers. MOODTM has previously announced supply agreements with TSX listed companies Inner Spirit Holdings (CSE: ISH) for their Spiritleaf retail outlets and Westleaf (TSX-V: WL) for their Prairie Records retail outlets.



Read more

Specialized Security Firms Enter the Cannabis Market Space

2019-02-15 08:00:30

NEW YORK, Feb. 15, 2019 /CNW/ -- The demand for security in the cannabis sector has increased substantially as more businesses are becoming operational and as a result, companies involved in fields such as cultivation, retail, and distribution are seeking security services. Primarily, security service companies dabbling in the cannabis industry offer services such as armored transportation, surveillance, alarms, sensors, and on-site guards. According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023. Furthermore, the market is forecast to accelerate at a healthy CAGR of 37% throughout the forecast period from 2019 to 2024. 3 Sixty Risk Solutions Ltd. (OTC: PTVYF) (CSE: SAFE), Beleave Inc. (OTC: BLEVF) (CSE: BE), KushCo Holdings, Inc. (OTC: KSHB), Emerald Health Therapeutics, Inc. (OTC: EMHTF) (TSX-V:EMH), AXIM Biotechnologies, Inc. (OTC: AXIM)

As more states and countries begin to legalize cannabis, more businesses are being granted licenses to operate. Similar to many other industries, they require outside resources such as advisory, finance, law, and security. However, due to federal regulatory laws, certain public sectors such as banks are barred from working with cannabis-related companies. As a result, these mandated regulatory laws have caused the emergence of specific public and private sectors within the cannabis industry itself. "Because most major banks are regulated at a federal level, and cannabis is still prohibited federally, businesses that operate in states where cannabis is legal are still unable to put their money in banks or operate business banking accounts. Why does this matter? Well, this creates a need to move large amounts of cash safely, therefore bringing in the need for armored vehicles. Beyond cash, cannabis businesses need a secure way to move valuable products and inventory, and we're talking very valuable products," Chris Laurenzo wrote in a post on The DMS Group.

3 Sixty Risk Solutions Ltd. (OTC: PTVYF) (CSE: SAFE) is also listed on the Canadian Securities Exchange under the ticker (CSE: SAFE). Yesterday, 3 Sixty Risk Solutions Ltd. announced that the Company, "which operates through its wholly-owned subsidiary, 3 Sixty Secure Corp., is providing secure transport services to Beleave Inc. ("Beleave") (CSE: BE) for its medical and non-medical cannabis products. Headquartered in Oakville, Ontario, Beleave cultivates high-quality cannabis flower and oil, for the medical and recreational markets where it can be found under the Seven Oaks brand. The company has developed a network of medical cannabis clinics in Ontario and Quebec and has been awarded a retail network in Saskatchewan and has been pre-qualified for retail in Manitoba. Additionally, through its international investments, Beleave has access to the Latin American and European markets.

'We are extremely pleased to be providing secure transport services to Beleave,' said Thomas Gerstenecker, CEO and Founder of 3 Sixty. 'Beleave is vertically integrated in the medical and recreational cannabis markets within Canada with significant growth plans. It is available in 100% of Canada's medical cannabis markets and over 55% of the recreational market with plans to roll out recreational cannabis distribution to 99.57% of Canadians before the close of 2020. We are excited to partner with a progressive company like Beleave that has a vision for meeting the needs of Canadians but also has an eye on international expansion which aligns with our own strategic growth plans.'

'We continue to grow our customer base, which includes top-tier LP's, distributors and retailers across Canada, by providing world-class security services to our top-tier customer base," added Thomas Gerstenecker. "We intend to remain a leader in cannabis-focused security by meeting and exceeding our customer's stringent demands within the highly regulated cannabis industry. We will continue to seek new services to offer to our existing customers as well as looking beyond our borders for geographic expansion opportunities that allow us to export our expertise across Canada, the US and internationally through organic means and by executing on disciplined M&A.'


Read more

BNN Bloomberg Identifies Indiva as Rapidly Growing in the Cannabis Sector

2019-02-15 08:00:00


LONDON, ON, Feb. 15, 2019 /CNW/ - Indiva Limited (the "Company" or "Indiva") (TSX:NDVA) (US:NDVAF):  On BNN Bloomberg this Saturday February 16 and Sunday February 17, 2019 - BTV- Business Television visits five distinctive companies in the rapidly growing cannabis sector.

One of the companies identified is Indiva and the episode features our commitment to the edibles market through the upcoming release of a line of chocolates and cannabis-infused sugar and salt products.

Further, President and CEO Niel Marotta discusses Indiva's current lineup of dried flower and pre-rolls, which will soon be available through the Ontario Cannabis Store, as well as the eventual introduction of gel capsules and oil tinctures. Indiva's segment can be seen here: See Feature

BTV is a half-hour weekly investment program, which profiles emerging companies across Canada and the US to bring investors information for their portfolio. With Hosts Taylor Thoen and Jessica Katrichak, BTV interviews experts, top analysts, plus features companies at their location giving investors an insightful business perspective.


Read more

CannAmerica Signs LOI to Enter the European CBD Market

2019-02-15 08:00:00

VANCOUVER, Feb. 15, 2019 /CNW/ - CANNAMERICA BRANDS CORP. ("CannAmerica Brands" or the "Company") (CSE: CANA) (OTCQB: CNNXF) is pleased to announce that on February 14, 2019 it entered into a letter of intent ("LOI") to provide an exclusive license to manufacture and distribute CannAmerica Brands branded CBD infused products in Europe with Winchester MD Limited ("Winchester").

Winchester is a Europe based arms-length entity that operates a revenue producing online retailer under the brand HempElf and offers a variety of CBD products through its store.  Winchester is seeking property in a number of regions in Europe for their new manufacturing facility, which CannAmerica Brands is not required to provide funding for.

CannAmerica Brands and Winchester intend to enter into a definitive agreement by April 15, 2019.  Under the terms of the LOI CannAmerica Brands will provide Winchester with supplies and equipment in exchange for a per unit royalty payment that is to be determined in the definitive agreement.

"The Company is excited to expand CannAmerica Brand's reach into Europe and thrilled to be doing so with a partner that has been quickly building a reputation as a provider of high-quality CBD products" said Dan Anglin, CEO and Co-Founder of CannAmerica Brands.

For more information, please visit www.cannamericabrands.com.


Read more

Origin House Announces Strategic Partnership with Premium Cannabis Brand Kurvana for Exclusive Distribution Rights in Northern California

2019-02-15 07:00:55

OTTAWA, Feb. 15, 2019 /CNW/ - CannaRoyalty Corp. d/b/a Origin House (CSE: OH) (OTCQX: ORHOF) ("Origin House" or the "Company"), a leading North American cannabis products and brands company, today announced that the Company has signed a memorandum of understanding ("MOU") to take over the exclusive distribution of Kurvana products across Northern California, thus terminating Kurvana's distribution arrangements with other third-party distributors in that region. As part of the MOU, the parties have also agreed to explore the transition of distribution in Southern California, subject to fulfilment of mutually acceptable conditions.

Kurvana is the leading premium vape pen brand in California, currently ranked as the fifth1 brand in revenue overall in California. Origin House's subsidiary, RVR, has distributed Kurvana-branded products since December 2015 and has historically held non-exclusive distribution rights in Northern California.

"Through its unique approach of creative engineering, scientific discovery, and manufacturing excellence, Kurvana has established itself as the leading premium California cannabis brand with impressive revenue growth, year over year," said Afzal Hasan, President and General Counsel at Origin House. "As an existing distributor of Kurvana-branded products in Northern California, we have first-hand insight into the brand's popularity and potential for future success. Through this arrangement, we are excited to reinforce our relationship with Kurvana and support its mission of delivering best-in-class cannabis products to California's discerning consumers. We are confident that our partnership will form a solid foundation for Kurvana's growth trajectory, while offering significant benefits to Origin House shareholders."

"Our number one priority for 2019 is to solidify Kurvana's dominance in the California market, the largest cannabis market worldwide," said Drew Cesario, Regional Sales Manager at Kurvana. "A strategic partnership with Origin House and their extensive distribution platform will be a key component to accelerated growth in the Northern California region. We are thrilled to deepen our relationship with Origin House and optimistic for the year ahead."

Under the Company's brand acceleration program, Origin House has agreed to provide strategic financing of up to US$10 million (the "Financing") to Kurvana under a promissory note. Up to US$4 million of the Financing will be available to Kurvana to draw on immediately and the remaining US$6 million will be available subject to fulfillment of certain conditions.


Read more

Aphria Announces Conclusion of Special Committee Review

2019-02-15 07:00:42

Special Committee concludes that acquisition of LATAM assets was within an acceptable range as compared to similar acquisitions by competitors

Review also involved independent physical inspection of operating LATAM assets, confirming facilities, licenses and employment

Provides recommendations for further governance enhancements

Company provides update on executive transitions

LEAMINGTON, ON, Feb. 15, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Board of Directors (the "Board") has accepted and considered the report of the special committee of independent directors (the "Special Committee"), which reviewed the allegations made against the Company in respect of the Company's previously completed acquisition of LATAM Holdings Inc. (the "Acquisition").


Read more

3 Sixty Risk Solutions Commences Trading on the Frankfurt Stock Exchange

2019-02-15 07:00:00


ALMONTE, ON, Feb. 15, 2019 /CNW/ - 3 Sixty Risk Solutions Ltd. ("3 Sixty" or the "Company") (CSE: SAFE) (FSE: 62P2), which operates through its wholly-owned subsidiary, 3 Sixty Secure Corp., is pleased to announce that it has commenced trading on the Frankfurt Stock Exchange ("FSE") under the securities identification code "WKN: A2PBNJ" and the ticker symbol "62P2". The Company's common shares continue to be listed on the Canadian Securities Exchange under the ticker symbol "SAFE".

"3 Sixty has global ambitions and listing our shares on the Frankfurt Stock Exchange is an important milestone for the Company," said Thomas Gerstenecker, CEO and Founder of 3 Sixty. "The FSE is one of the world's largest trading centres for securities and the largest of Germany's seven stock exchanges. Our listing in Europe provides improved access for global investors seeking to invest in quality, Canadian companies with exposure to high-growth, legal cannabis markets. I believe that this will further support our organic growth agenda and help to accelerate our international expansion plans by executing on disciplined M&A."

About 3 Sixty Risk Solutions Ltd.

3 Sixty Risk Solutions Ltd., operating through its wholly-owned subsidiary, 3 Sixty Secure Corp., is one of Canada's leading security service providers to the cannabis sector, transporting approximately $250 million of product every month. 3 Sixty provides cannabis security consulting, guarding and secure transport security services to more than 500 customers and more than 60 licensed cannabis producers, including some of the world's largest, such as licensed producers owned by Canopy Growth Corporation. 3 Sixty has a staff of over 275 employees and employs a fleet of over 60 vehicles, which management believes provides a combined security footprint to approximately 30 million square feet of patrolled area.


Read more

/R E P E A T -- Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M/

2019-02-15 06:00:00

SMITHS FALLS, ON, Feb. 14, 2019 /CNW/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or "the Company") today released its consolidated financial results for the third quarter fiscal 2019 ended December 31, 2018.  All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

Third Quarter Fiscal 2019 Operational and Financial Highlights

Q3 2019

Q3 2018


Read more

Pivot Pharma Develops Transdermal Patch for Delivery of CBD and THC

2019-02-15 04:00:20

Formulated Using Pivot's Thrudermic™ Transdermal Nanotechnology

VANCOUVER, Feb. 15, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that the Company has completed the development of a controlled-release transdermal patch system for the delivery of cannabinoids. Thrudermic™ is a proven technology for penetration through the skin and reaching the blood stream without altering the skin structure. The patch uses the Thrudermic™ nanotechnology developed by Dr. Leonid Lurya and Dr. Joseph Borovsky at Pivot's Contract Laboratory in Israel.  The process entails formulating a nanoparticle in a phospholipid matrix and suspended in a gel. The patch is assembled by coating it with Thrudermic™ gel containing a cannabinoid, for single use applications. Depending on the formulation, the Thrudermic™ patch can be designed for quick onset or sustained release presentations.

Key Thrudermic™ Transdermal Patch Attributes:

Dr. Joseph Borovsky, Pivot's Chairman and Executive Vice President, Technology, commented, "I am very pleased to add yet another product to Pivot's industry leading bio-cannabis portfolio. Our competitive advantage is producing consistent products using patented and proven drug delivery systems that result in the formulation of disruptive solutions for the cannabis industry. All our products improve the absorption of cannabinoids into the body allowing the user better exposure to the natural ingredient that they choose. As the market develops and consumers begin to understand that tropical oils or fish oils are ineffective delivery systems, they will demand consistent, high-quality and effective products. Pivot's products are much more sophisticated than just coconut oil or shea butter mixtures and they address the fact that current products on the market lack standardization, appropriate controls, and bioavailability. Pivot has solved these problems by borrowing from the pharma industry playbook. Pivot will manufacture and distribute the Thrudermic™ Transdermal Patch through its existing extensive global partnerships, where regulations permit."


Read more

Grow Biotech, ECH and IPS Specials Facilitate First Batch of Medical Cannabis to UK for Multiple Patients

2019-02-15 01:00:00

LONDON, Feb. 15, 2019 /CNW/ -- Today, Grow Biotech, ECH and IPS Specials have made history by importing the first bulk shipment of cannabis-based medicines to the UK since the Home Office formally acknowledged the medical benefits of cannabis last November - marking a significant step forward for the fledgling British legal cannabis industry, while greatly improving the ease of access for patients.

British medical cannabis start-up Grow Biotech collaborated with IPS Specials and European Cannabis Holdings (ECH) to facilitate the import. Grow Biotech's team of specialists made this possible by working alongside doctors to address their concerns regarding quality assurance and compliance for the prescriptions they have written, bridging the gap between existing cannabis medicines and accepted pharmaceutical standards.

The shipment has been exported by the Office of Medical Cannabis of the Netherlands and will be delivered directly to the patients from a pharmacy in the UK, with additional stock retained to ensure continuity of supply. The stock includes Bedrocan Flower Afina, and Bedica Flower Talea, which are used to treat a range of conditions including chronic pain and multiple sclerosis.

Dr. David McDowell, who sits on the ECH's medical board said, "The fact that we are now in a position to write prescriptions that can actually be fulfilled is a huge achievement. Patients no longer need to worry about how they can access their medication, which will mark a positive step change in their journey and finally provide the relief that they are looking for, and we can now finally provide."

This will lay the cornerstone for the British medical cannabis industry's international supply chain and proves that challenging regulations can be adhered to through innovation and creativity.


Read more